TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MDXG

MiMedx Group Inc

Healthcare · Biotechnology

4.80$ +0.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

MiMedx Group Inc (MDXG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 419 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MDXG
Line item 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.8 7.8 27 59 118 187 245 321 359 359 248 242 268 321 349 419
1.7 3.2 5.2 9.3 13 20 32 35 36 36 39 40 48 55 60 73
-0.9 4.6 22 50 106 167 213 286 323 323 209 202 220 267 289 346
0.1 2.0 2.0 4.0 2.8 2.6 2.9 4.8 7.1 8.4 14 18 16 16 12 9.9 13 13 12 15
0.6 8.7 8.0 8.0 6.8 12 20 46 90 133 170 216 253 253 181 198 209 207 225 266
0.0 0.0 11 12 9.6 14 27 52 98 143 191 240 327 327 254 209 234 230 230 281
0.0 0.0 -18 -12 -11 -9.8 -2.0 -2.6 7.1 24 0.9 46 -3.9 -3.9 -45 -7.1 -15 37 59 64
0.0 0.0 0.0 0.0 0.6 0.4 2.3 1.4 0.0 0.1 0.3 0.1 0.0 0.0 7.9 5.0 5.0 6.5 1.0 1.8
0.0 0.0 -17 -12 -11 -10 -7.7 -4.0 7.1 24 0.5 45 -3.4 -3.4 -62 -12 -20 31 57 66
-0.5 -0.5 0.1 0.9 0.4 2.3 0.1 0.8 -5.2 6.1 -20 27 27 -12 0.2 0.2 -37 15 18
0.0 0.0 -17 -12 -11 -10 -7.7 -4.1 6.2 29 12 65 -30 -30 -49 -12 -30 67 42 49
0.0 0.5 -11 -11 -9.7 -8.0 -0.1 -0.6 9.2 27 8.9 53 3.0 18 -38 -1.9 -11 41 65 83

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?